General
Preferred name
Josamycin
Synonyms
EN-141 ()
EN-141, Kitasamycin A3, Leucomycin A3, Turimycin A5 ()
Jomybel ()
Turimycin a5 ()
Josamicina ()
Josamycin propionate ()
Josamycine ()
Kitasamycin a3 ()
Leucomycin a3 ()
Iosalide ()
Josamina ()
P&D ID
PD009564
CAS
16846-24-5
Tags
available
drug
natural product
Drug indication
premature birth
Bacterial infection
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Josamycin (EN-141) is an orally active macrolide antibiotic exhibiting antimicrobial activity against a wide spectrum of pathogens, such as bacteria. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM[1][2].
PRICE
35
DESCRIPTION
Josamycin is a 16-membered macrolide antibacterial compound that is identical to leucomycin A3 . It is obtained from fermentation of the actinomycete Streptomyces narbonensis.
(GtoPdb)
DESCRIPTION
Josamycin (EN-141) is a macrolide antibiotic with antimicrobial activity, characterized by a ribosomal dissociation constant (Kd) of 5.5 nM.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
31
Molecular Weight
827.47
Hydrogen Bond Acceptors
16
Hydrogen Bond Donors
3
Rotatable Bonds
12
Ring Count
3
Aromatic Ring Count
0
cLogP
3.01
TPSA
206.05
Fraction CSP3
0.81
Chiral centers
16.0
Largest ring
16.0
QED
0.15
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
antibiotic
Bacterial
Indication
bronchitis
MOA
bacterial 50S ribosomal subunit inhibitor
Pathway
Microbiology/virology
Anti-infection
Therapeutic Class
Antibiotics
Source data

